| 000 | 01007 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250517012500.0 | ||
| 264 | 0 | _c20171205 | |
| 008 | 201712s 0 0 eng d | ||
| 022 | _a1699-3993 | ||
| 024 | 7 |
_a10.1358/dot.2014.50.12.2235103 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFulchiero, E | |
| 245 | 0 | 0 |
_aNivolumab. _h[electronic resource] |
| 260 |
_bDrugs of today (Barcelona, Spain : 1998) _cDec 2014 |
||
| 300 |
_a791-802 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aNivolumab |
| 700 | 1 | _aJimeno, A | |
| 773 | 0 |
_tDrugs of today (Barcelona, Spain : 1998) _gvol. 50 _gno. 12 _gp. 791-802 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1358/dot.2014.50.12.2235103 _zAvailable from publisher's website |
| 999 |
_c24533298 _d24533298 |
||